Advertisement

Topics

Rgenix to Present Poster on RGX-202 at the 2018 AACR Annual Meeting

10:50 EDT 16 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today that Isabel Kurth, PhD, Vice President of Research at Rgenix, will present a pos...

Other Sources for this Article

Media:
RooneyPartners
Marion Janic, 212-223-4017
mjanic@rooneyco.com

NEXT ARTICLE

More From BioPortfolio on "Rgenix to Present Poster on RGX-202 at the 2018 AACR Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...